\n\t\t\t\t\t\t\t\t\t\t\t\tMar 9, 2026\t\t\t\t\t<\/p>\n
According to a report from Yahoo Finance, Novo Nordisk<\/a> has agreed to dismiss a patent infringement lawsuit against Hims & Hers Health Inc.<\/a> after the two companies reached an agreement. The deal will result in Novo Nordisk<\/a>‘s branded weight loss medications being sold through the Hims & Hers<\/a> platform.<\/p>\n Following the announcement, shares of Hims & Hers Health Inc. rose more than 40% in Monday morning trading. The legal dispute began early last month when Hims & Hers stated it would launch a lower-cost, off-brand version of the weight-loss pill Wegovy. This announcement came weeks after Novo Nordisk introduced a reformulated version of the medication. At that time, Novo Nordisk pledged to take legal action, characterizing the planned product as an unapproved and untested imitation of semaglutide.<\/p>\n Hims & Hers abandoned its plan to offer the off-brand version just two days later. This decision followed a warning from the Food and Drug Administration<\/a> that it might restrict access to ingredients used to copy popular weight-loss drugs. The FDA allows compounded versions of brand-name drugs during shortages, and high demand for GLP-1 medications in recent years led several companies to enter the market.<\/p>\n In 2024, the FDA declared that GLP-1 drugs were no longer in shortage, a status change typically ending the allowance for compounding. However, companies continued sales by using an exception for prescriptions customized for individual patients. Under the new agreement announced on Monday, Hims & Hers will offer both oral and injectable versions of Wegovy and Ozempic on its platform later this month. The company will also cease advertising compounded GLP-1 drugs on its platform and in its marketing materials.<\/p>\n Novo Nordisk stated it retains the right to refile its lawsuit in the future.<\/p>\n This report provides a comprehensive view of the global medicaments containing corticosteroid hormones industry, tracking demand, supply, and trade flows across the worldwide value chain. It explains how demand across key channels and end-use segments shapes consumption patterns, while also mapping the role of input availability, production efficiency, and regulatory standards on supply.<\/p>\n Beyond headline metrics, the study benchmarks prices, margins, and trade routes so you can see where value is created and how it moves between exporters and importers worldwide. The analysis is designed to support strategic planning, market entry, portfolio prioritization, and risk management in the global medicaments containing corticosteroid hormones landscape.<\/p>\n Quick navigation Global demand is shaped by both household and industrial usage, with trade flows linking cost-competitive producers to import-reliant markets. The report combines market sizing with trade intelligence and price analytics. It covers both historical performance and the forward outlook to 2035, allowing you to compare cycles, structural shifts, and policy impacts across countries and regions.<\/p>\n Market size and growth in value and volume terms For the global report, country profiles provide a consistent view of market size, trade balance, prices, and per-capita indicators. The profiles highlight the largest consuming and producing markets and allow direct benchmarking across peers.<\/p>\n Methodology<\/p>\n The analysis is built on a multi-source framework that combines official statistics, trade records, company disclosures, and expert validation. Data are standardized, reconciled, and cross-checked to ensure consistency across time series.<\/p>\n International trade data (exports, imports, and mirror statistics) All data are normalized to a common product definition and mapped to a consistent set of codes. This ensures that comparisons across time are aligned and actionable.<\/p>\n Forecasts to 2035<\/p>\n The forecast horizon extends to 2035 and is based on a structured model that links medicaments containing corticosteroid hormones demand and supply to macroeconomic indicators, trade patterns, and sector-specific drivers. The model captures both cyclical and structural factors and reflects known policy and technology shifts.<\/p>\n Historical baseline: 2012-2025 Each country projection is built from its own historical pattern and the regional context, allowing the report to show where growth is concentrated and where risks are elevated.<\/p>\n Price analysis and trade dynamics<\/p>\n Prices are analyzed in detail, including export and import unit values, regional spreads, and changes in trade costs. The report highlights how seasonality, freight rates, exchange rates, and supply disruptions influence pricing and margins.<\/p>\n Price benchmarks by country and sub-region Key producers, exporters, and distributors are profiled with a focus on their operational scale, geographic footprint, product mix, and market positioning. This helps identify competitive pressure points, partnership opportunities, and routes to differentiation.<\/p>\n Business focus and production capabilities Quantify global demand and identify the most attractive markets This report is designed for manufacturers, distributors, importers, wholesalers, investors, and advisors who need a clear, data-driven picture of global medicaments containing corticosteroid hormones dynamics.<\/p>\n FAQ The market size aggregates consumption and trade data at country and regional levels, presented in both value and volume terms.<\/p>\n How are the forecasts to 2035 built?<\/p>\n The projections combine historical trends with macroeconomic indicators, trade dynamics, and sector-specific drivers.<\/p>\n Does the report cover prices and margins?<\/p>\n Yes, it includes export and import unit values, regional spreads, and a pricing outlook to 2035.<\/p>\n Which countries are profiled in detail?<\/p>\n The report provides profiles for the largest consuming and producing countries, enabling benchmarking across peers.<\/p>\n Can this report support market entry decisions?<\/p>\n Yes, it highlights demand hotspots, trade routes, pricing trends, and competitive context.<\/p>\n \t\t1. INTRODUCTION<\/p>\n Making Data-Driven Decisions to Grow Your Business<\/p>\n \t\t\t\tREPORT DESCRIPTION \t\t2. EXECUTIVE SUMMARY<\/p>\n A Quick Overview of Market Performance<\/p>\n
\nKey findings<\/p>\n
\n Pricing dynamics reflect unit values, freight costs, exchange rates, and regulatory shifts that affect sourcing decisions.
\n Supply depends on input availability and production efficiency, creating distinct cost curves across regions.
\n Market concentration varies by country, creating different competitive landscapes and entry barriers.
\n The 2035 outlook highlights where capacity investment and demand growth are most aligned globally.
\nReport scope<\/p>\n
\n Consumption structure by end-use segments and regions
\n Production capacity, output, and cost dynamics
\n Global trade flows, exporters, importers, and balances
\n Price benchmarks, unit values, and margin signals
\n Competitive context and market entry conditions
\nProduct coverageProdcom 21201270 – Medicaments containing corticosteroid hormones, their derivatives and structural analogues, put up in measured doses or for retail saleCountry coverageCountry profiles and benchmarks<\/p>\n
\n National production and consumption statistics
\n Company-level information from financial filings and public releases
\n Price series and unit value benchmarks
\n Analyst review, outlier checks, and time-series validation<\/p>\n
\n Forecast horizon: 2026-2035
\n Scenario-based sensitivity to income growth, substitution, and regulation
\n Capacity and investment outlook for major producing countries<\/p>\n
\n Export and import unit value trends
\n Seasonality and calendar effects in trade flows
\n Price outlook to 2035 under baseline assumptions
\nProfiles of market participants<\/p>\n
\n Geographic reach and distribution networks
\n Cost structure and pricing strategy indicators
\n Compliance, certification, and sustainability context
\nHow to use this report<\/p>\n
\n Evaluate export opportunities and prioritize target countries
\n Track price dynamics and protect margins
\n Benchmark performance against major competitors
\n Build evidence-based forecasts for investment decisions<\/p>\n
\nWhat is included in the global medicaments containing corticosteroid hormones market?<\/p>\n
\n\t\t\t\tRESEARCH METHODOLOGY AND THE AI PLATFORM
\n\t\t\t\tDATA-DRIVEN DECISIONS FOR YOUR BUSINESS
\n\t\t\t\tGLOSSARY AND SPECIFIC TERMS<\/p>\n